Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System
Artivion Inc AORT
$22.67
▼ -0.26%
($-0.06)
Open
$22.62
Prev Close
$22.73
Day Range
$21.76 – $23.16
52W Range
$19.16 – $48.25
Market Cap
$1.10B
P/E (TTM)
118.82
Beta
1.40
EPS (TTM)
$0.20
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 1993-02-12 |
| Shares Out. | 48,540,000 |
| Website | artivion.com/ ↗ |
| Phone | 17704193355 |
Artivion Inc is a publicly traded company under the ticker symbol AORT on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-05-01)
📰 Latest News for AORT
Artivion Completes Acquisition of Endospan Ltd.
Earnings High Fliers And Busts
Artivion Inc (NYSE:AORT) Catches the GARP Eye With Affordable Growth Screen
Artivion (AORT) Price Target Decreased by 16.86% to 43.73
Artivion, Inc. 2026 Q1 - Results - Earnings Call Presentation
Artivion, Inc. (AORT) Q1 2026 Earnings Call Transcript
Transcript : Artivion, Inc., Q1 2026 Earnings Call, May 07, 2026